Royalty Pharma plc (RPRX)
Royalty Pharma plc Revenue
| Dec'15 | Dec'16 | Dec'17 | Dec'18 | Dec'19 | Dec'20 | Dec'21 | Dec'22 | Dec'23 | |
|---|---|---|---|---|---|---|---|---|---|
| Revenue | $1,652.4M | $1,877.4M | $1,597.9M | $1,794.9M | $1,814.3M | $2,122.0M | $2,289.5M | $2,237.2M | $2,354.6M |
Royalty Pharma plc (RPRX) Revenue comparison analysis
RPRX key stats
Discover more Stock Ideas
Undervalued stocks right now
Discover the top 20 best undervalued stocks to buy for Jan 2025, listed on the Nasdaq or NYSE.
Undervalued growth stocks
Discover the top 20 best undervalued large-cap growth stocks to buy for Jan 2025, listed on the Nasdaq or NYSE.
Undervalued dividend stocks
Discover the top 20 best undervalued high-yield dividend stock that offers both growth potential and attractive dividend returns for Jan 2025.
investors
worldwide
FAQ
1) What is Royalty Pharma plc's Revenue?
As of today, Royalty Pharma plc's last 12-month Revenue is $2,265.9M, based on the financial report for Sep 30, 2024 (Q3 2024).
2) What is Royalty Pharma plc's Revenue growth rate?
Over the last year, Royalty Pharma plc's Revenue growth was (2.5%). The average annual Revenue growth rates for Royalty Pharma plc have been 1.1% over the past three years, 10.8% over the past five years.
3) Is Royalty Pharma plc's Revenue growth rate Good?
Over the last year, Royalty Pharma plc's Revenue growth was (2.5%), which is lower than industry growth of 3.0%. It indicates that Royalty Pharma plc's Revenue growth is Bad.